Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2015 07:00 ET | Source: Auspex Pharmaceuticals, Inc.

Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting

LA JOLLA, Calif., March 27, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late-clinical stage biopharmaceutical company dedicated to developing innovative medicines for people...
March 16, 2015 16:01 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Reports Fourth Quarter 2014 Results and Business Highlights

LA JOLLA, Calif., March 16, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late-clinical stage biopharmaceutical company dedicated to developing innovative medicines for people...
February 23, 2015 06:30 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex to Present at the Cowen Healthcare Conference

LA JOLLA, Calif., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement...
February 03, 2015 06:30 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of SD-809 in Tardive Dyskinesia

LA JOLLA, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement...
February 02, 2015 16:00 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex to Present at the 2015 Leerink Global Healthcare Conference

LA JOLLA, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement...
January 28, 2015 16:00 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

LA JOLLA, Calif., Jan. 28, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement...
January 23, 2015 07:27 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Announces Pricing of Follow on Offering

LA JOLLA, Calif., Jan. 23, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement...
January 21, 2015 16:32 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Announces Proposed Public Offering of Common Stock

LA JOLLA, Calif., Jan. 21, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement...
January 14, 2015 13:34 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Receives FDA Orphan Drug Designation of SD-809 for Treatment of Tourette Syndrome in the Pediatric Population

LA JOLLA, Calif., Jan. 14, 2015 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a biopharmaceutical company dedicated to developing innovative medicines for people with movement...
January 12, 2015 09:19 ET | Source: Auspex Pharmaceuticals, Inc.

Auspex Pharmaceuticals Announces SD-1077 Program for the Potential Treatment of Parkinson's Disease and Related Movement Disorders

Auspex to Acquire Remaining Worldwide Rights to SD-1077 Through Purchase of Imphar AG Clinical Proof-Of-Concept Data for SD-1077 Versus Levodopa Expected in 2016 LA JOLLA, Calif., Jan. 12, 2015...